Cód QR

Setmelanotide-mediated MC4R activation improves hypothalamic obesity via CaMKK2/AMPK pathways

Hypothalamic obesity (HO) is a disabling disease caused by central nervous system (CNS) damage due to neurosurgery, trauma, or tumors, especially in hypothalamus. The pathological mechanism of its neural circuits is still unclear, and there is currently no corresponding drug due to the complex etiol...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Junjie Peng, Yichao Ou, Mingfeng Zhou, Xingqin Wang, Xi’an Zhang, Hao Long, Guangsen Wu, Mengjie Che, Kai Li, Le Yang, Zhu Zhang, Ken Kin Lam Yung, Songtao Qi, Zhanpeng Feng
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: Frontiers Media S.A. 2026-01-01
Sraith:Frontiers in Pharmacology
Ábhair:
CaMKK2/AMPK signaling
GPCRs
hypothalamic obesity
melanocortin 4 receptor
neuropharmacology
setmelanotide
Rochtain ar líne:https://www.frontiersin.org/articles/10.3389/fphar.2025.1730786/full
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla